ICAM1 and neoplasm: Interestingly, it has been reported that ET-1 released by ovarian cancer cells may affect the recruitment of TIL to the tumor via ETBR, reducing the expression of the endothelial intercellular adhesion molecule 1 (ICAM1), therefore interfering with the TIL homing to the tumor [68].